Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain

Michele J Buonora; Minhee L Sung; Caroline G Falker; Anne C Black; William C Becker

doi:10.1001/jamanetworkopen.2022.41670

Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain

JAMA Netw Open. 2022 Nov 1;5(11):e2241670. doi: 10.1001/jamanetworkopen.2022.41670.

Authors

Michele J Buonora^{1

2

3}, Minhee L Sung^{2

4}, Caroline G Falker^{2

3}, Anne C Black^{2

4}, William C Becker^{2

4}

Affiliations

¹ National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut.
² Department of Internal Medicine & Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut.
³ General Internal Medicine, Veterans Affairs Connecticut Healthcare System, West Haven.
⁴ Pain Research, Informatics, Multimorbidities & Education Center of Innovation, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.

No abstract available

Plain language summary

This cross-sectional study of US adults examines the prevalence of and characteristics associated with prescribed buprenorphine use among US adults with pain-motivated nonmedical use of prescription opioids.

Publication types

Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural

MeSH terms

Adult
Analgesics, Opioid* / therapeutic use
Buprenorphine* / therapeutic use
Humans
Pain / drug therapy
Prescriptions
Self Report

Substances

Analgesics, Opioid
Buprenorphine

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States